5 unknown. 5 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Unknown 5 |
| Phase 1 | 2 | Unknown 2 |
Follow Progressive Supranuclear Palsy: new trials by email Literature Review of Progressive Supranuclear Palsy trials Research Report on Progressive Supranuclear Palsy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RT001 in Patients With Progressive Supranuclear Palsy (PSP) PROGRESSIVE SUPRANUCLEAR PALSY RT001, Placebo - Progressive Supranuclear Palsy | Phase 2 | Unknown | Biojiva LLC | 40 | 2021-06-23 | 2021-06-25 |
| Rho Kinase (ROCK) Inhibitor in Tauopathies - 1 Fasudil - Progressive Supranuclear Palsy, Corticobasal Syndrome | Phase 2 | Unknown | Woolsey Pharmaceuticals | 15 | 2021-01-22 | 2022-06-03 |
| Evaluation of Tolfenamic Acid in Individuals With PSP at 12-Weeks Tolfenamic Acid, Placebos - Progressive Supranuclear Palsy | Phase 1 / Phase 2 | Unknown | NeuroTau, Inc. | 24 | 2021-01-01 | 2020-02-05 |
| Clinical Trial to Evaluate Bone Marrow Stem Cell Therapy for PSP, a Rare Form of Parkinsonism stem cell therapy - Progressive Supranuclear Palsy | Phase 1 / Phase 2 | Unknown | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 25 | 2012-12-01 | 2013-04-04 |
| Efficacy Study for Treatment of Dementia in Progressive Supranuclear Palsy rivastigmine - Progressive Supranuclear Palsy, Dementia | Phase 2 | Unknown | University Hospital Tuebingen | 20 | 2008-02-01 | 2008-02-18 |
Supranuclear Palsy, Progressive (5) · Corticobasal Degeneration (1) · Dementia (1)
Basal Ganglia Diseases (5) · Brain Diseases (5) · Central Nervous System Diseases (5) · Cranial Nerve Diseases (5) · Eye Diseases (5) · Movement Disorders (5) · Nervous System Diseases (5) · Neurodegenerative Diseases (5) · Neurologic Manifestations (5) · Ocular Motility Disorders (5) · Ophthalmoplegia (5) · Paralysis (5) · Pathological Conditions, Signs and Symptoms (5) · Signs and Symptoms (5) · Tauopathies (5)
RT001 (1) · Rivastigmine (1) · Safflower Oil (1) · fasudil (1) · tolfenamic acid (1)
Biojiva LLC (1) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (1) · NeuroTau, Inc. (1) · University Hospital Tuebingen (1) · Woolsey Pharmaceuticals (1)
Germany (2) · United States (2) · Italy (1)
Daniela Berg, Doctor (1) · Marwan Sabbagh, MD (1) · Nasser Zawia, PhD (1) · Peter Ljubenkov, MD (1) · Rosaria Giordano, MD (1) · Stefan Lorenzl, MD, PhD (1)